公开(公告)号：EP1532104A1

公开(公告)日：2005-05-25

申请号：EP03771813.7

申请日：2003-07-25

申请人： Theravance, Inc.

发明人： LINSELL, Martin, S. ,  JACOBSEN, John, R. ,  KHOSSRAVI, Davar ,  PABORJI, Mehdi ,  ZHANG, Weijiang

IPC分类号： C07C233/43 ,  A61K31/165 ,  A61P11/00 ,  C07C209/16

CPC分类号： C07C213/04 ,  C07C215/30 ,  C07C233/43

摘要： The invention provides a crystalline salt form of a novel β2 adrenergic receptor agonist. The invention also provides pharmaceutical compositions comprising the crystalline form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt form to treat diseases associated with β2 adrenergic receptor activity, and processes useful for preparing such a crystalline compound.